All (n = 47,022) | Non-VFR (n = 40,569) | VFR (n = 6453) | |||
---|---|---|---|---|---|
N (%) | N (%) | N (%) | cOR (95% CI) | aOR (95% CI)a | |
HAV | |||||
1st dose | 13,130 (27.9%) | 11,469 (28.3) | 1661 (25.7) | 0.88 (0.83–0.93) | 0.59 (0.55–0.64) |
2nd dose | 3024 (6.4%) | 2732 (6.7) | 292 (4.5) | 0.66 (0.58–0.74) | 0.56 (0.48–0.65) |
HBV | |||||
1st dose | 212 (0.5%) | 198 (0.5) | 14 (0.2) | 0.44 (0.26–0.76) | 0.35 (0.18–0.70) |
2nd dose | 75 (0.2%) | 67 (0.2) | 8 (0.1) | 0.75 (0.36–1.56) | 0.99 (0.46–2.17) |
3rd dose | 34 (0.1%) | 31 (0.1) | 3 (0.1) | 0.61 (0.19–1.99) | 0.51 (0.12–2.18) |
HAV + HBV | |||||
1st dose | 2039 (4.3%) | 1852 (4.6) | 187 (2.9) | 0.62 (0.54–0.73) | 0.61 (0.51–0.72) |
2nd dose | 442 (0.9%) | 418 (1.0) | 24 (0.4) | 0.35 (0.24–0.54) | 0.35 (0.21–0.61) |
3rd dose | 167 (0.4%) | 150 (0.4) | 17 (0.3) | 0.71 (0.43–1.18) | 0.73 (0.41–1.30) |
Tetanus | |||||
DTPa | 350 (0.7%) | 307 (0.8) | 43 (0.7) | 0.88 (0.64–1.21) | 0.85 (0.58–1.24) |
Td booster | 5706 (12.1%) | 5109 (12.6) | 597 (9.3) | 0.71 (0.65–0.77) | 0.66 (0.59–0.73) |
Influenza | 1014 (2.2%) | 955 (2.4) | 59 (0.9) | 0.38 (0.29–0.50) | 0.43 (0.28–0.64) |
MMR | 395 (0.8%) | 326 (0.8) | 69 (1.1) | 1.33 (1.03–1.73) | 0.77 (0.52–1.13) |
Polio | 3111 (6.6%) | 2775 (6.8) | 336 (5.2) | 0.75 (0.67–0.84) | 0.70 (0.61–0.81) |
Yellow fever | 15,558 (33.1%) | 12,439 (30.7) | 3119 (48.3) | 2.12 (2.01–2.23) | 2.00 (1.88–2.13) |
Typhoid | |||||
Oral vaccine | 4090 (8.7%) | 3485 (8.6) | 605 (9.4) | 1.10 (1.01–1.20) | 1.15 (1.00–1.29) |
IM vaccine | 30,507 (64.9%) | 26,437 (65.2) | 4070 (63.4) | 0.91 (0.86–0.96) | 0.79 (0.74–0.85) |
Rabies | |||||
1st dose | 1125 (2.4%) | 1069 (2.6) | 56 (0.9) | 0.32 (0.27–0.42) | 0.22 (0.16–0.31) |
2nd dose | 88 (0.2%) | 84 (0.2) | 4 (0.1) | 0.30 (0.11–0.81) | 0.26 (0.08–0.86) |
3rd dose | 51 (0.1%) | 51 (0.1) | 0 (0) | – | – |
Meningococcus | 5280 (11.2%) | 4110 (10.1) | 1170 (18.1) | 1.96 (1.83–2.11) | 3.01 (2.72–3.33) |
Cholera | 2493 (5.3%) | 2278 (5.6) | 215 (3.3) | 0.61 (0.53–0.71) | 0.68 (0.58–0.80) |